Cancer Therapies

Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) were trading higher by nearly 5 percent late Friday morning after the company announced that the U.S. Food and Drug Administration (FDA) has accepted its EOquin for New Drug Application (NDA) for review. EOquin (apaziquone for intravesical...

Clovis Oncology Inc (NASDAQ: CLVS) announced on Friday that the U.S. Food and Drug Administration has scheduled a date of April 12, 2016 to discuss a New Drug Application for its rociletinib therapy. Rociletinib is an investigational therapy for the treatment of patients with mutant epidermal...

Shares of TrovaGene Inc (NASDAQ: TROV), a development-stage molecular diagnostic company, were trading higher by nearly 20 percent on Monday after the company announced that it has entered into an agreement with FedMEd, a proprietary Preferred Provider Organization consisting of over 550,000...